Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3-(4-(1h-imidazol-1-ylmethyl)phenyl)-2-propenoic Acid
2. 4-(1-imidazoylmethyl)cinnamic Acid
3. Oky 046
4. Oky-046
5. Ozagrel, Monohydrochloride
6. Ozagrel, Monohydrochloride, (e)-isomer
7. Sodium Ozagrel
1. 82571-53-7
2. Ozagrel [inn]
3. Oky-046
4. (e)-3-(4-((1h-imidazol-1-yl)methyl)phenyl)acrylic Acid
5. Ozagrel Free Acid
6. Kct-0809
7. Domenan
8. (e)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic Acid
9. Chembl11662
10. (e)-p-(imidazol-1-ylmethyl)cinnamic Acid
11. L256jb984d
12. 82571-53-7 (free Base)
13. Ozagrel (inn)
14. Ozagrelum [latin]
15. Pulmoza
16. Ozagrelum
17. 3-[4-(1h-imidazol-1-ylmethyl)phenyl]-2e-propenoic Acid
18. 2-propenoic Acid, 3-[4-(1h-imidazol-1-ylmethyl)phenyl]-, (2e)-
19. Unii-l256jb984d
20. Cataclot (tn)
21. Ozagrel,(s)
22. Ozagrel, Oky-046
23. Ozagrel [mi]
24. 2-propenoic Acid, 3-(4-(1h-imidazol-1-ylmethyl)phenyl)-, (e)-
25. 3-[4-(1-imidazolylmethyl)phenyl]-2-propenoic Acid
26. Ozagrel [mart.]
27. Prestwick2_000979
28. Prestwick3_000979
29. Ozagrel [who-dd]
30. Schembl4210
31. Bspbio_001017
32. Bpbio1_001119
33. Gtpl9866
34. Oky046
35. Zinc5389
36. Dtxsid6048547
37. Chebi:92359
38. Chebi:134938
39. Hms2089o14
40. Hms3649m21
41. Hms3884n21
42. Bcp12147
43. Ex-a5744
44. Hy-b0428
45. Bdbm50017896
46. Mfcd00868231
47. S2496
48. Akos015889403
49. Ac-2080
50. Ccg-266782
51. Db12017
52. Ncgc00025195-02
53. As-71327
54. Ls-14195
55. Sbi-0207081.p001
56. Ab00514722
57. Sw197369-5
58. 3-(4-imidazol-1-ylmethyl-phenyl)-acrylic Acid
59. D08327
60. (e)-3-(4-((1h-imidazol-1-yl)methyl)phenyl)
61. Ab00514722-10
62. Ab00514722-12
63. Ab00514722-13
64. Ab00514722_14
65. Ab00514722_15
66. 4-(1h-imidazole-1-ylmethyl)benzenepropenoic Acid
67. 571o537
68. (e)-3-(4-imidazol-1-ylmethyl-phenyl)-acrylic Acid
69. Q-100843
70. Q7116436
71. Sr-01000597793-8
72. 3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic Acid
73. Brd-k19525698-003-01-1
74. Brd-k53061490-003-03-0
75. (e)-3-[4-(1h-imidiazol-1-ylmethyl)phenyl]-2-propenic Acid
76. (2e)-3-[4-(1h-imidazol-1-ylmethyl)phenyl]acrylic Acid
77. (2e)-3-{4-[(1h-imidazol-1-yl)methyl]phenyl}prop-2-enoic Acid
78. (e)-3-[p-(1h-imidazol-1-ylmethyl)phenyl]-2-propenoic Acid
| Molecular Weight | 228.25 g/mol |
|---|---|
| Molecular Formula | C13H12N2O2 |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 228.089877630 g/mol |
| Monoisotopic Mass | 228.089877630 g/mol |
| Topological Polar Surface Area | 55.1 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 283 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Histamine Antagonists
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Fibrinolytic Agents
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)
ABOUT THIS PAGE
46
PharmaCompass offers a list of pulmoza API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right pulmoza manufacturer or pulmoza supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred pulmoza manufacturer or pulmoza supplier.
PharmaCompass also assists you with knowing the pulmoza API Price utilized in the formulation of products. pulmoza API Price is not always fixed or binding as the pulmoza Price is obtained through a variety of data sources. The pulmoza Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A pulmoza manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of pulmoza, including repackagers and relabelers. The FDA regulates pulmoza manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. pulmoza API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A pulmoza supplier is an individual or a company that provides pulmoza active pharmaceutical ingredient (API) or pulmoza finished formulations upon request. The pulmoza suppliers may include pulmoza API manufacturers, exporters, distributors and traders.
pulmoza Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of pulmoza GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right pulmoza GMP manufacturer or pulmoza GMP API supplier for your needs.
A pulmoza CoA (Certificate of Analysis) is a formal document that attests to pulmoza's compliance with pulmoza specifications and serves as a tool for batch-level quality control.
pulmoza CoA mostly includes findings from lab analyses of a specific batch. For each pulmoza CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
pulmoza may be tested according to a variety of international standards, such as European Pharmacopoeia (pulmoza EP), pulmoza JP (Japanese Pharmacopeia) and the US Pharmacopoeia (pulmoza USP).
